CYP2A6 genetic variation and dexmedetomidine disposition

PURPOSE: There is a large interindividual variability in dexmedetomidine dose requirements for sedation of patients in intensive care units (ICU). Cytochrome P450 2A6 (CYP2A6) mediates an important route of dexmedetomidine metabolism, and genetic variation in CYP2A6 affects the clearance of other su...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kohli, Utkarsh, Pandharipande, Pratik, Muszkat, Mordechai, Sofowora, Gbenga G., Friedman, Eitan A., Scheinin, Mika, Wood, Alastair J. J., Ely, E. Wesley, Tyndale, Rachel F., Choi, Leena, Stein, C. Michael, Kurnik, Daniel
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3352974/
https://ncbi.nlm.nih.gov/pubmed/22271297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-011-1208-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items